The present disclosure provides methods for treating multiple myeloma (such asrefractory multiple myeloma or relapsed and refractory multiple myeloma) in anindividual whoreceived at least two prior therapies for multiple myeloma. The methodscomprise administering tothe individual an anti-CD38 antibody, pomalidomide, and dexamethasone.